Characterization of the "Gs-like" activity of Xlas
Xlas“类 Gs”活性的表征
基本信息
- 批准号:6895226
- 负责人:
- 金额:$ 12.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-01 至 2006-06-30
- 项目状态:已结题
- 来源:
- 关键词:G proteinallelesbiological signal transductiondisease /disorder modelfamily geneticsgene expressiongene mutationgenetically modified animalsin situ hybridizationkidneylaboratory mousemolecular pathologypathologic ossificationprotein structureprotein structure functionpseudohypoparathyroidismreceptor bindingrenal tubulesex linked trait
项目摘要
DESCRIPTION (provided by applicant):
The alpha subunit of the stimulatory G protein (Gsalpha), and its large variant XLalphas, are derived from GNAS1 through the use of alternative promoters and pre-mRNA splicing. XLalphas, unlike Gsalpha, shows limited tissue distribution, including expression in kidney, and is expressed paternally in all investigated tissues. Despite having distinct amino-terminal domains, the two proteins are identical over a long stretch of carboxyl-terminal amino acids comprising almost all the structural features characterized for Gsalpha. Thus, XLalphas and Gsalpha may have similar functional properties in the cell, and our recently published results are consistent with this hypothesis. Given the importance of Gsalpha in numerous different biological responses, the "Gs-like" activity of XLalphas may also have significant roles in the body. Heterozygous inactivating mutations within Gsalpha-encoding exons of GNASI are associated with multiple phenotypes that show parent-specific inheritance, including pseudohypoparathyroidism (PHP), progressive osseous heteroplasia (POH), and Albright's hereditary osteodystrophy (AHO). After paternal transmission, most of these mutations are predicted to disrupt both Gsalpha and XLalphas, suggesting that pathogenesis of some of these disorders, such as POH, may involve not only the deficiency of Gsalpha but also of XLalphas. Moreover, in disorders that develop after maternal inheritance, such as PHP-Ia, the activity of XLalphas expressed from the intact paternal allele may provide compensatory "Gs-like" signaling in certain cells, thereby contributing to the selectivity of hormone resistance in certain types of PHP. My main objective is thus to further explore the role of the "Gs-like" activity of XLalphas in the molecular and genetic mechanisms underlying these diseases. My first specific aim involves a more detailed in vitro characterization of XLas, and to compare its functional properties with those of Gsalpha, particularly regarding possible receptor selectivity and differential effects of naturally-occurring GNASI mutations. I will also identify the unique XLalphas-specific features that are important for its signaling activity. In addition, I will examine spatial and temporal expression of XLalphas in the kidney to therefore provide further insights into possible involvement of XLas in actions mediated by parathyroid hormone in this tissue. Finally, I will determine whether XLalphas can have "Gs-like" activity in vivo, by generating an animal model with targeted expression of XLalphas in the renal proximal tubule. These studies will be helpful in clarifying the biological roles of XLalphas, and may furthermore improve the current understanding of the GNASl-related disorders.
描述(由申请人提供):
刺激性G蛋白(Gsalpha)的α亚基及其大变体XLalphas通过使用替代启动子和前mRNA剪接而衍生自GNAS 1。与Gsalpha不同,XLalphas显示有限的组织分布,包括在肾脏中的表达,并且在所有研究的组织中父系表达。尽管有不同的氨基末端结构域,这两种蛋白质是相同的,在很长一段羧基末端的氨基酸,包括几乎所有的结构特征Gsalpha。因此,XLalphas和Gsalpha在细胞中可能具有相似的功能特性,我们最近发表的结果与这一假设一致。鉴于Gsalpha在许多不同的生物反应中的重要性,XLalphas的“GS样”活性也可能在体内发挥重要作用。GNASI的Galpha编码外显子内的杂合失活突变与显示父母特异性遗传的多种表型相关,包括假性甲状旁腺功能减退症(PHP)、进行性骨发育不全(POH)和奥尔布赖特遗传性骨营养不良(AHO)。父系传播后,这些突变中的大多数被预测为破坏Gsalpha和XLalphas,这表明这些疾病中的一些,如POH的发病机制,可能涉及不仅缺乏Gsalpha,但也XLalphas。此外,在母系遗传后发展的疾病中,如PHP-Ia,从完整的父系等位基因表达的XLalphas的活性可以在某些细胞中提供补偿性的“GS样”信号传导,从而有助于某些类型的PHP中激素抗性的选择性。因此,我的主要目标是进一步探索XLalphas的“GS样”活性在这些疾病的分子和遗传机制中的作用。我的第一个具体目标涉及更详细的体外表征XLas,并将其功能特性与Gsalpha的功能特性进行比较,特别是关于可能的受体选择性和天然存在的GNASI突变的差异效应。我还将确定其信号活性的重要的独特的XLovias特定功能。此外,我将检查XLalphas在肾脏中的空间和时间表达,从而进一步了解XLas可能参与该组织中甲状旁腺激素介导的作用。最后,我将确定是否XLalphas可以有“GS样”的活动在体内,通过产生一个动物模型与靶向表达XLalphas在肾近曲小管。这些研究将有助于阐明XLalpha的生物学作用,并可能进一步提高目前对GNAS 1相关疾病的理解。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS.
常染色体显性 Ib 型假性甲状旁腺功能减退症与杂合微缺失有关,该微缺失可能会破坏 GNAS 推定的印记控制元件。
- DOI:10.1172/jci19159
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Bastepe,Murat;Fröhlich,LeopoldF;Hendy,GeoffreyN;Indridason,OlafurS;Josse,RobertG;Koshiyama,Hiroyuki;Körkkö,Jarmo;Nakamoto,JonM;Rosenbloom,ArlanL;Slyper,ArnoldH;Sugimoto,Toshitsugu;Tsatsoulis,Agathocles;Crawford,JohnD;Jüpp
- 通讯作者:Jüpp
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MURAT BASTEPE其他文献
MURAT BASTEPE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MURAT BASTEPE', 18)}}的其他基金
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling
GPCR/Gq/PKC 信号传导介导的骨骼 FGF23 产生
- 批准号:
10376665 - 财政年份:2020
- 资助金额:
$ 12.99万 - 项目类别:
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling
GPCR/Gq/PKC 信号传导介导的骨骼 FGF23 产生
- 批准号:
10365935 - 财政年份:2020
- 资助金额:
$ 12.99万 - 项目类别:
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling
GPCR/Gq/PKC 信号传导介导的骨骼 FGF23 产生
- 批准号:
10598571 - 财政年份:2020
- 资助金额:
$ 12.99万 - 项目类别:
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling
XLalphas 作为 Gs 的新型 α 亚基在激素信号传导中的作用
- 批准号:
8003287 - 财政年份:2010
- 资助金额:
$ 12.99万 - 项目类别:
XLas Relative to Gsa in Bone and Mineral Ion Metabolism
XLas 在骨和矿物质离子代谢中相对于 Gsa
- 批准号:
8675845 - 财政年份:2007
- 资助金额:
$ 12.99万 - 项目类别:
XLas Relative to Gsa in Bone and Mineral Ion Metabolism
XLas 在骨和矿物质离子代谢中相对于 Gsa
- 批准号:
8852595 - 财政年份:2007
- 资助金额:
$ 12.99万 - 项目类别:
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling
XLalphas 作为 Gs 的新型 α 亚基在激素信号传导中的作用
- 批准号:
7475183 - 财政年份:2007
- 资助金额:
$ 12.99万 - 项目类别:
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling
XLalphas 作为 Gs 的新型 α 亚基在激素信号传导中的作用
- 批准号:
7777465 - 财政年份:2007
- 资助金额:
$ 12.99万 - 项目类别:
XLas Relative to Gsa in Bone and Mineral Ion Metabolism
XLas 在骨和矿物质离子代谢中相对于 Gsa
- 批准号:
8549199 - 财政年份:2007
- 资助金额:
$ 12.99万 - 项目类别:
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling
XLalphas 作为 Gs 的新型 α 亚基在激素信号传导中的作用
- 批准号:
7667806 - 财政年份:2007
- 资助金额:
$ 12.99万 - 项目类别:
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 12.99万 - 项目类别:
Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
- 批准号:
10590033 - 财政年份:2024
- 资助金额:
$ 12.99万 - 项目类别:
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 12.99万 - 项目类别:
Drivers and consequences of introgression in evolution
进化中基因渗入的驱动因素和后果
- 批准号:
10552299 - 财政年份:2023
- 资助金额:
$ 12.99万 - 项目类别:
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 12.99万 - 项目类别:
Modulation of NOD Strain Diabetes by ENU-Induced Mutations
ENU 诱导突变对 NOD 菌株糖尿病的调节
- 批准号:
10642549 - 财政年份:2023
- 资助金额:
$ 12.99万 - 项目类别:
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
靶向端粒酶逆转录酶 (TERT) 的突变启动子
- 批准号:
10677899 - 财政年份:2023
- 资助金额:
$ 12.99万 - 项目类别:
Characterizing Entorhinal Cortex Circuit Dysfunction in an APOE Mouse Model of Chemotherapy-Induced Cognitive Impairment
化疗引起认知障碍的 APOE 小鼠模型中内嗅皮层回路功能障碍的特征
- 批准号:
10677984 - 财政年份:2023
- 资助金额:
$ 12.99万 - 项目类别: